Compare CRDF & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRDF | BCML |
|---|---|---|
| Founded | 1999 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 130.7M | 317.2M |
| IPO Year | 2012 | 2018 |
| Metric | CRDF | BCML |
|---|---|---|
| Price | $1.58 | $29.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $9.63 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 552.3K | 17.0K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 4.05% |
| EPS Growth | ★ 27.37 | 3.81 |
| EPS | N/A | ★ 2.18 |
| Revenue | ★ $365,993.00 | N/A |
| Revenue This Year | N/A | $13.71 |
| Revenue Next Year | N/A | $5.25 |
| P/E Ratio | ★ N/A | $13.58 |
| Revenue Growth | ★ 49.61 | N/A |
| 52 Week Low | $1.48 | $22.22 |
| 52 Week High | $4.56 | $33.15 |
| Indicator | CRDF | BCML |
|---|---|---|
| Relative Strength Index (RSI) | 35.65 | 55.90 |
| Support Level | $1.51 | $29.17 |
| Resistance Level | $1.68 | $30.61 |
| Average True Range (ATR) | 0.09 | 0.74 |
| MACD | -0.02 | 0.12 |
| Stochastic Oscillator | 7.87 | 76.59 |
Cardiff Oncology Inc is a clinical-stage biotechnology company that leverages PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies for various cancers with unmet medical needs. The company focuses on targeting tumor vulnerabilities with treatment combinations of onvansertib, its oral and selective PLK1 inhibitor, and standard-of-care (SoC) therapeutics. The firm's clinical program pipeline focuses on indications such as RAS-mutated metastatic colorectal cancer (mCRC), investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC), metastatic triple negative breast cancer (mTNBC), and Chronic Myelomonocytic Leukemia (CMML). Geographically, it operates only in the United States.
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses, and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services. The Company operates as one reportable segment: banking operations.